Cancers
短名 | |
Journal Impact | 4.50 |
国际分区 | ONCOLOGY(Q1) |
期刊索引 | SCI Q2中科院 2 区 |
ISSN | 2072-6694 |
h-index | 133 |
国内分区 | 医学(2区)医学肿瘤学(3区) |
CANCERS (ISSN 2072-6694) 是一本经过同行评审的国际肿瘤学开放获取期刊。它发表评论、定期研究论文和简短的交流。我们的目标是鼓励科学家尽可能详细地发表他们的实验和理论结果。论文的长度没有限制。必须提供完整的实验细节,以便重现结果。
期刊主页投稿网址涉及主题 | 医学生物内科学遗传学癌症化学生物化学癌症研究病理基因免疫学肿瘤科外科细胞生物学放射科 |
出版信息 | 出版商: Multidisciplinary Digital Publishing Institute (MDPI),出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2009,原创研究文献占比: 67.26%,自引率:11.10%, Gold OA占比: 99.52% |
平均审稿周期 | 期刊官网数据:平均18.07天网友分享经验:11 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Histopathological Growth Patterns Determine the Outcomes of Colorectal Cancer Liver Metastasis Following Liver Resection
2024-9-13
Atypical Spindle Cell/Pleomorphic Lipomatous Tumor: A Review and Update
2024-9-13
Local Invasion Patterns Characterized by SARIFA and Tumor Budding Differ and Have Distinct Prognostic Significance in Esophageal Adenocarcinoma and Squamous Cell Carcinoma
2024-9-13
A Qualitative Study of the Knowledge of Metabolic Syndrome, Attitudes about Lifestyle Modifications, and Preferences for Lifestyle Interventions among Patients with Cancer and Metabolic Syndrome
2024-9-13
The Adenosinergic Pathway in Non-Small Cell Lung Cancer
2024-9-13
Diffusion-Weighted Magnetic Resonance Imaging for the Diagnosis of Lymph Node Metastasis in Patients with Biliary Tract Cancer
2024-9-13
Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas
2024-9-13
Adrenal Insufficiency following Stereotactic Ablative Radiotherapy (SAbR) of Adrenal Gland Metastases
2024-9-12
Characterization of HER2-Low Breast Tumors among a Cohort of Colombian Women
2024-9-12
Role of Percutaneous Endoscopic Gastrostomy for the Nutrition of Head and Neck Cancer Patients before and up to 6 Months after Cancer Treatment
2024-9-12
WEE1 Inhibitor Adavosertib Exerts Antitumor Effects on Colorectal Cancer, Especially in Cases with p53 Mutations
2024-9-12
Is End-Stage Renal Disease Tumor Suppressive? Dispelling the Myths
2024-9-12
Inflammation-Associated Stem Cells in Gastrointestinal Cancers: Their Utility as Prognostic Biomarkers and Therapeutic Targets
2024-9-12
Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy
2024-9-12
Integrated Psychological Services in Pediatric Oncology: Caregiver Perspectives at Diagnosis
2024-9-12
Ferroptosis in Renal Cancer Therapy: A Narrative Review of Drug Candidates
2024-9-11
New Advances in the Study of CMTM6, a Focus on Its Novel Non-Canonical Cellular Locations, and Functions beyond Its Role as a PD-L1 Stabilizer
2024-9-11
Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer
2024-9-11
Dermatofibrosarcoma Protuberans: An Updated Review of the Literature
2024-9-11
BRAF Inhibition and UVB Light Synergistically Promote Mus musculus Papillomavirus 1-Induced Skin Tumorigenesis
2024-9-11
Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis
2024-9-11
Ollier Disease, Acute Myeloid Leukemia, and Brain Glioma: IDH as the Common Denominator
2024-9-11
Proton Therapy Adaptation of Perisinusoidal and Brain Areas in the Cyclotron Centre Bronowice in Krakow: A Dosimetric Analysis
2024-9-11
The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine
2024-9-11
MCMC Methods for Parameter Estimation in ODE Systems for CAR-T Cell Cancer Therapy
2024-9-11
Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI)
2024-9-10
Conjunctival Melanoma: A Clinical Review and Update
2024-9-10
Dual-Action Therapeutics: DNA Alkylation and Antimicrobial Peptides for Cancer Therapy
2024-9-10
Model-Informed Radiopharmaceutical Therapy Optimization: A Study on the Impact of PBPK Model Parameters on Physical, Biological, and Statistical Measures in 177Lu-PSMA Therapy
2024-9-10
The Role of Pulmonary Collectins, Surfactant Protein A (SP-A) and Surfactant Protein D (SP-D) in Cancer
2024-9-10
The Role of Circulating Tumor DNA in Ovarian Cancer
2024-9-10
Radiomics-Based Computed Tomography Urogram Approach for the Prediction of Survival and Recurrence in Upper Urinary Tract Urothelial Carcinoma
2024-9-10
Current Advances and Challenges in the Management of Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients
2024-9-10
The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies
2024-9-9
Rhabdomyosarcoma of the Biliary Tract in Children: Analysis of Single Center Experience
2024-9-9
Clinical Interest in Exome-Based Analysis of Somatic Mutational Signatures for Non-Small Cell Lung Cancer
2024-9-9
Cellular and Microbial In Vitro Modelling of Gastrointestinal Cancer
2024-9-9
Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Non-Metastatic Non-Small-Cell Lung Cancer Who Are Not Candidates for or Decline Surgery and Chemotherapy: A Practical Proposal by the International Geriatric Radiotherapy Group
2024-9-9
The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer
2024-9-9
Minimal Requirements for Cancer Initiation: A Comparative Consideration of Three Prototypes of Human Leukemia
2024-9-9
Impact of Indocyanine Green Dose on Sentinel Lymph Node Mapping in Cervical Cancer: A Systematic Review
2024-9-8
Curcumin-Dichloroacetate Hybrid Molecule as an Antitumor Oral Drug against Multidrug-Resistant Advanced Bladder Cancers
2024-9-8
Brain Metastases as Inaugural Sign of Non-Small Cell Lung Carcinoma: Case Series and Review of Literature
2024-9-8
Amitotic Cell Division, Malignancy, and Resistance to Anticancer Agents: A Tribute to Drs. Walen and Rajaraman
2024-9-8
Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors
2024-9-7
HLA-A01 and HLA-B27 Supertypes, but Not HLA Homozygocity, Correlate with Clinical Outcome among Patients with Non-Small Cell Lung Cancer Treated with Pembrolizumab in Combination with Chemotherapy
2024-9-7
Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance
2024-9-7
Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma
2024-9-6
Scoping Review: Methods and Applications of Spatial Transcriptomics in Tumor Research
2024-9-6
Deep Learning Model for Predicting Lung Adenocarcinoma Recurrence from Whole Slide Images
2024-9-6
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远